e-ISSN: 2717-7149
  • Home
  • About The Journal
  • Editorial Board
  • Instructions for Authors
  • Contact
Current Issue
Ahead Of Print
Archive
Search
Most Popular
Download Articles Read Articles
Retina Arter Tıkanıklıkları ve Tedavisi...
Santral Retinal Ven Tıkanıklığı Güncel Tedavisi...
Central Retinal Artery Occlusion As the Cause of Unilateral Concentric Narrowing of Visual Field and Presence of Cilioretinal Artery...
Bilateral Optic Disc Drusen
Vascular Endothelial Growth Factor and Anti VEGF Agents...
Central Retinal Artery Occlusion As the Cause of Unilateral Concentric Narrowing of Visual Field and Presence of Cilioretinal Artery...
Retina Arter Tıkanıklıkları ve Tedavisi...
Morning Glory Syndrome Associated with Retinochoroidal Coloboma...
Santral Retinal Ven Tıkanıklığı Güncel Tedavisi...
Bilateral Optic Disc Drusen
PureSee Kesintisiz Yüksek Kalitede Görüş
Retina-Vitreous 2014 , Vol 22 , Num 4
Turkish Abstract Abstract Article PDF Similar Articles Mail to Author
The Results of VFQ-25 and Gazi VFQ-10 After Single Dose of Intravitreal Anti-VEGF Treatment
Burçin KEPEZ YILDIZ1, Nuriye Gökçen YALÇIN2, Şengül ÖZDEK3, Berati HASANREİSOĞLU3
1M.D. Yozgat State Hospital, Eye Clinic, Yozgat/TURKEY
2M.D. Asistant, Gazi University Faculty of Medicine, Department of Ophthalmology, Ankara/TURKEY
3M.D. Professor, Gazi University Faculty of Medicine, Department of Ophthalmology, Ankara/TURKEY
Purpose: To examine the reliability of the life quality questionnaire Gazi VFQ-10 which we composed to make a shorter and understandable form of National Eye Institute Visual Functioning Questionnaire-25 (VFQ-25) that is worldwidely used and investigate their correlation.

Material and Method: 26 patients who've been planned to take intravitreal anti VEGF injections because of age related macular degeneration, choroidal neovascular membrane of various causes, diabetic macular edema, vein occlusion were included. They were given VFQ-25 and Gazi VFQ-10 questionnaires at first visit. One month after the intravitreal injection, following routine ophthalmologic examination, these questionnaires were given again. The changes in scores of these questionnaires after treatment were detected and the correlation between visual acuity changes were investigated.

Results: 17 men, 9 women were participated and the mean age was 62.92±10.3 (40-80). The best corrected visual acuity ( BCVA) was 0.71±0.5 logMAR before treatment and 0.68±0.5 logMAR at the first month(p>0.05). Pretreatment general average VFQ-25 score was 60.7±20.3 (27.5-94.3) and 61.36±21.06 (25.7-94.46) at the first month after treatment (p>0.05). For Gazi VFQ-10 average score was 2.38±0.78 at the first visit and 2.65±0.85 at the first month (p: 0.038). Pretreatment and after treatment scores of VFQ-25 and Gazi VFQ-10 had significant correlation(before treatment r:0.934, p<0.001; after treatment r:0.727, p<0.001).But the changes in scores were not correlated with the change of BCVA for any of these questionnaires.

Conclusion: Because it is more understandable and practical than VFQ-25, Gazi VFQ-10 seems to be appropriate for clinical use. Keywords : VFQ-25, anti VEGF, life quality

PureSee Kesintisiz Yüksek Kalitede Görüş
Home
About The Journal
Editorial Board
Instructions for Authors
Contact